Tech Company Financing Transactions

Adaptive Phage Therapeutics Funding Round

Alexandria Venture Investments participated in a $7 million funding round for Adaptive Phage Therapeutics. The round was announced on 10/8/2019.

Transaction Overview

Announced On
10/8/2019
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds will be deployed to support multi-center phase 2 clinical studies for its PhageBank therapy for antibiotic resistant bacterial infections.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
708 Quince Orchard Rd. 205
Gaithersburg, MD 20878
USA
Email Address
Overview
Adaptive Phage Therapeutics, Inc. (APT) is a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria.
Profile
Adaptive Phage Therapeutics LinkedIn Company Profile
Social Media
Adaptive Phage Therapeutics Company Twitter Account
Company News
Adaptive Phage Therapeutics News
Facebook
Adaptive Phage Therapeutics on Facebook
YouTube
Adaptive Phage Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Gregory Merril
  Gregory Merril LinkedIn Profile  Gregory Merril Twitter Account  Gregory Merril News  Gregory Merril on Facebook
Chief Medical Officer
Michael Brownstein
  Michael Brownstein LinkedIn Profile  Michael Brownstein Twitter Account  Michael Brownstein News  Michael Brownstein on Facebook
Chief Operating Officer
Subhendu Basu
  Subhendu Basu LinkedIn Profile  Subhendu Basu Twitter Account  Subhendu Basu News  Subhendu Basu on Facebook
Chief Scientific Officer
Carl Merril
  Carl Merril LinkedIn Profile  Carl Merril Twitter Account  Carl Merril News  Carl Merril on Facebook
Vice President
Robert Hopkins
  Robert Hopkins LinkedIn Profile  Robert Hopkins Twitter Account  Robert Hopkins News  Robert Hopkins on Facebook
VP - Bus. Development
Michael King
  Michael King LinkedIn Profile  Michael King Twitter Account  Michael King News  Michael King on Facebook
VP - Finance
Michael Orndorff
  Michael Orndorff LinkedIn Profile  Michael Orndorff Twitter Account  Michael Orndorff News  Michael Orndorff on Facebook
VP - Manufacturing
Joseph Fackler
  Joseph Fackler LinkedIn Profile  Joseph Fackler Twitter Account  Joseph Fackler News  Joseph Fackler on Facebook
VP - Product Management
Robert Cohen
  Robert Cohen LinkedIn Profile  Robert Cohen Twitter Account  Robert Cohen News  Robert Cohen on Facebook
VP - Regulatory Affairs
Amy Fix
  Amy Fix LinkedIn Profile  Amy Fix Twitter Account  Amy Fix News  Amy Fix on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/8/2019: Viola venture capital transaction
Next: 10/8/2019: Evrnu venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary